PhD program objectives
The objectives of the PhD program in Innovative Health Technologies and Products include:
-
Promoting the design of innovative products and technologies for human and animal health.
-
Equipping doctoral candidates to conduct interdisciplinary research in health products, pharmaceutical development, and medical and surgical technologies.
-
Developing skills from design to synthesis and pharmaceutical analysis, including aspects related to drug delivery for both synthetic and biotechnological drugs.
-
Evaluating the effectiveness of developed systems through in vitro and in vivo approaches.
-
Providing expertise in industrial and regulatory transfer.
-
Deepening the understanding of clinical transfer and preclinical phases, with a focus on clinically relevant pathologies.
-
Developing and experimenting with innovative diagnostic and therapeutic techniques.
-
Exploring the application of artificial intelligence in the pharmaceutical and health sectors, aiming to improve existing practices and therapies.
-
Expanding international collaboration through partnerships with institutions to enrich the doctoral experience through continuous participation of doctoral candidates at international locations.
Employment and professional prospects envisioned
Doctoral graduates will have numerous professional outlets, being able to work in various sectors, including:
• Pharmaceutical and Biotechnological Companies: They will contribute to the development of innovative drugs using advanced techniques such as modeling, in vivo and in silico preclinical models, organoids, and/or mono/pluricellular systems that replicate the functioning of tissues or organs. They may be involved in the entire drug development process, from discovery to clinical phase.
• Healthcare Companies: They will participate in identifying therapeutic targets for drug repurposing, thereby improving available therapies for various conditions. Additionally, they may be involved in developing innovative medical devices, thereby enhancing diagnostic and therapeutic practices.
• Academic and University Research: They may pursue an academic career as researchers or university lecturers, contributing to the advancement of scientific knowledge in the field of health and medical technologies.
• Cellular and Molecular Biology Sector: They will refine cellular and molecular biology techniques through the adoption of technological innovations, thereby contributing to understanding the biological mechanisms underlying diseases and treatments.
• Patient Care Pathway Improvement: They will collaborate with healthcare institutions and medical organizations to enhance patient care pathways. This could include updating guidelines for specific pathologies, implementing new therapies, and optimizing treatment protocols.
In summary, doctoral graduates will have the opportunity to significantly contribute to research and development in the pharmaceutical, biotechnological, and healthcare sectors, directly impacting clinical practice and patient well-being.